Cargando…

Drug Combinations in Breast Cancer Therapy

Breast cancer therapy involves a multidisciplinary approach com-prising surgery, radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires maximum therapeutic efficacy, with mini-mal undesirable effects to ensure a good quality of life for patients. The carefully se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fisusi, Funmilola A., Akala, Emmanuel O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691849/ https://www.ncbi.nlm.nih.gov/pubmed/30666921 http://dx.doi.org/10.2174/2211738507666190122111224

Ejemplares similares

Studies on polyethylene glycol-monoclonal antibody conjugates for fabrication of nanoparticles for biomedical applications
por: Fisusi, Funmilola, et al.
Publicado: (2020)

Neurotransmitters and molecular chaperones interactions in cerebral malaria: Is there a missing link?
por: Daniyan, Michael Oluwatoyin, et al.
Publicado: (2022)

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
por: Obidiro, Onyinyechi, et al.
Publicado: (2023)

Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect
por: Ejigah, Victor, et al.
Publicado: (2022)

Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels – A Strategy for Brain Cancer Treatments
por: Fisusi, Funmilola A., et al.
Publicado: (2016)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Computer Optimization of Biodegradable Nanoparticles Fabricated by Dispersion Polymerization
por: Akala, Emmanuel O., et al.
Publicado: (2015)

Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer
por: Cui, Ze-Jia, et al.
Publicado: (2021)

Cellular uptake and cytotoxicity studies of pH-responsive polymeric nanoparticles fabricated by dispersion polymerization
por: Puri, Reema, et al.
Publicado: (2018)

Gold Nanoparticles Mediated Drug-Gene Combinational Therapy for Breast Cancer Treatment
por: Shrestha, Binita, et al.
Publicado: (2020)

Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment
por: Ogunwuyi, Oluwaseun, et al.
Publicado: (2016)

A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy
por: Wang, Hairong, et al.
Publicado: (2021)

Combination Drug Delivery Approaches in Metastatic Breast Cancer
por: Lee, Jun H., et al.
Publicado: (2012)

Effective drug combinations in breast, colon and pancreatic cancer cells
por: Jaaks, Patricia, et al.
Publicado: (2022)

Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy
por: Yang, Tianshu, et al.
Publicado: (2021)

The role of complement immune response on artemisinin-based combination therapy in a population from malaria endemic region of Western Kenya
por: Wanjala, Christine N. L., et al.
Publicado: (2020)

In silico drug combination discovery for personalized cancer therapy
por: Jeon, Minji, et al.
Publicado: (2018)

Identification of synergistic drug combinations using breast cancer patient-derived xenografts
por: Turner, Tia H., et al.
Publicado: (2020)

Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
por: Meng, Jie, et al.
Publicado: (2016)

Combination of Conventional Drugs with Biocompounds Derived from Cinnamic Acid: A Promising Option for Breast Cancer Therapy
por: Meirelles, Lyvia Eloiza de Freitas, et al.
Publicado: (2023)

Updates on managing advanced breast cancer with palbociclib combination therapy
por: McShane, Teresa M., et al.
Publicado: (2018)

Breast Cancer Therapy Annual – today's drug treatment of cancer?
por: Cameron, David
Publicado: (2004)

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
por: Kinnel, Briana, et al.
Publicado: (2023)

Ex vivo and In vitro antiplasmodial activities of approved drugs predicted to have antimalarial activities using chemogenomics and drug repositioning approach
por: Ochora, Douglas O., et al.
Publicado: (2023)

Combination Therapies in Advanced, Hormone Receptor–Positive Breast Cancer
por: Olson, Emily
Publicado: (2018)

The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy
por: Chiou, Pey-Tsyr, et al.
Publicado: (2021)

Modeling breast cancer proliferation, drug synergies, and alternating therapies
por: He, Wei, et al.
Publicado: (2023)

Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy
por: Fan, Yuanyuan, et al.
Publicado: (2022)

HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model
por: Gou, Yi, et al.
Publicado: (2018)

Evaluation of side effects and compliance to chemotherapy in breast cancer patients at a Nigerian tertiary hospital
por: Folorunso, Sharif Adeniyi, et al.
Publicado: (2023)

Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination
por: Gilad, Yosi, et al.
Publicado: (2019)

Application of Novel Transcription Factor Machine Learning Model and Targeted Drug Combination Therapy Strategy in Triple Negative Breast Cancer
por: Pang, Jianyu, et al.
Publicado: (2023)

Study of New Therapeutic Strategies to Combat Breast Cancer Using Drug Combinations
por: Correia, Ana, et al.
Publicado: (2018)

Hypoxia as a target for drug combination therapy of liver cancer
por: Bowyer, Cressida, et al.
Publicado: (2017)

Stereotactic radiation therapy for breast cancer in the elderly
por: Jardel, Pauline, et al.
Publicado: (2020)

New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy
por: Kumar, Krishan, et al.
Publicado: (2022)

Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices
por: Sobowale, Christopher O., et al.
Publicado: (2020)

Cancer therapy disparity: unequal access to breast cancer therapeutics and drug funding in Canada
por: Verma, S., et al.
Publicado: (2007)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
por: Chalakur-Ramireddy, Naveen K.R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0a7fafdhoksp2uo3954hkt20t8